2017
DOI: 10.1016/j.lfs.2017.07.032
|View full text |Cite
|
Sign up to set email alerts
|

Binding effect of fluorescence labeled glycyrrhetinic acid with GA receptors in hepatocellular carcinoma cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
15
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(15 citation statements)
references
References 22 publications
0
15
0
Order By: Relevance
“…Glycyrrhetinic acid (GA), a pentacyclic triterpene derivative, is a major active agent extracted from liquorice (the root of Glycyrrhiza uralensis Fisch.) [13]. GA possessed extensive therapeutic effects, such as anti-cancer, anti-inflammatory and anti-viral effects [14].…”
Section: Introductionmentioning
confidence: 99%
“…Glycyrrhetinic acid (GA), a pentacyclic triterpene derivative, is a major active agent extracted from liquorice (the root of Glycyrrhiza uralensis Fisch.) [13]. GA possessed extensive therapeutic effects, such as anti-cancer, anti-inflammatory and anti-viral effects [14].…”
Section: Introductionmentioning
confidence: 99%
“…In doxorubicin-loaded CTS/PEG-GA nanoparticles (Tian et al, 2010), GA can target GA receptors on liver cancer cells. Also, GA receptors have been shown to be useful as liver-cancer targets in GA NFs (Sun et al, 2017). Similarly, in quercetin/Fe (III) (Bertleff-Zieschang et al, 2017) delivery, quercetin (as a phenolic compound) can form a complex organic-inorganic network with iron and gallic acid, and STE contributes to regulation of iron ions to form an "ideal" size of magnetic nanoparticles.…”
Section: The Endoperoxide Linkages (R-o-o-rmentioning
confidence: 99%
“…For example, lower pH (Chen et al., 2014; Lv et al., 2016; Hong et al., 2017) and higher glutathione (GSH) levels (Cheng et al., 2011; Raza et al., 2018) have been reported in TME. Studies on tumor surface proteins have reported the presence of multiple specific receptors, such as CD44 receptors (Chen et al., 2016, 2017a; Dong et al., 2018), folate receptors (Chen et al., 2017b), glycyrrhetinic acid receptors (Tian et al., 2012; Sun et al., 2017; Wang et al., 2018b; Yan et al., 2018), and transferrin receptors (Zhao et al., 2018). Based on the specificities of tumor cells, formulation workers have designed a range of targeted agents for the targeted delivery of anti-cancer drugs to tumor sites (Wang et al., 2018a, 2018c).…”
Section: Introductionmentioning
confidence: 99%